학술논문

Corrigendum to ‘Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis’ [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077]
Document Type
Erratum
Source
In Research and Practice in Thrombosis and Haemostasis May 2023 7(4)
Subject
Language
ISSN
2475-0379